Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [2]
- Other assay [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-15684 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Epo Monoclonal Antibody (4F11)
- Antibody type
- Monoclonal
- Antigen
- Purifed from natural sources
- Description
- MA5-15684 targets EPO in IF and WB applications and shows reactivity with Human samples.
- Antibody clone number
- 4F11
- Concentration
- Conc. Not Determined
Submitted references Chitosan and Hyaluronic Acid Nanoparticles as Vehicles of Epoetin Beta for Subconjunctival Ocular Delivery.
A therapeutic vascular conduit to support in vivo cell-secreted therapy.
Silva B, Gonçalves LM, Braz BS, Delgado E
Marine drugs 2022 Feb 18;20(2)
Marine drugs 2022 Feb 18;20(2)
A therapeutic vascular conduit to support in vivo cell-secreted therapy.
Han EX, Qian H, Jiang B, Figetakis M, Kosyakova N, Tellides G, Niklason LE, Chang WG
NPJ Regenerative medicine 2021 Jul 29;6(1):40
NPJ Regenerative medicine 2021 Jul 29;6(1):40
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of EPO using EPO monoclonal antibody (Product # MA5-15684) in HEK293 (1) and EPO (AA: 28-193) human IgG Fc transfected HEK293 (2) cell lysate.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence analysis of GC7901 cells using EPO monoclonal antibody (Product # MA5-15684) (Green). Blue: DRAQ5 fluorescent DNA dye. Red: actin filaments have been labeled with phalloidin.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence analysis of GC7901 cells using EPO monoclonal antibody (Product # MA5-15684) (Green). Blue: DRAQ5 fluorescent DNA dye. Red: actin filaments have been labeled with phalloidin.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 5 Immunofluorescent staining of EPO-TVC explant. TVC explant at 2 weeks stained with anti-EPO and anti-vimentin (FB marker) antibodies. Nuclei are stained with DAPI. TVC explant shows the outer layer of the TVC with EPO + FBs.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 7 EPO, W6/32, and F4/80 staining of TVC explants. Implants from control and EPO-TVCs (2 weeks to 4 months) were stained for EPO by immunofluorescence and W6/32 (human HLA Class I) and F4/80 (macrophage marker) by immunohistochemistry. Control grafts were only examined at 3- and 4-month time points. Means with standard deviations are indicated for EPO 3- and 4-month time points where n = 2. For other time points, n = 1.
